articles
Financial news
Results for the 2nd Quarter 2019
- FOLLOWING THE FAILURE OF OUR APPLICATION FOR A EUROPEAN SUBSIDY, ONE OF OUR SHAREHOLDER COMMITS TO RAISE THE BUDGET FOR PROOF OF EFFICACY - CC & C RECEIVES DELIVERANCE OF ITS PATENT FOR JAPAN AND THE USA On June 20th, we received the notification of rejection of...
read moreResults for the 1st Quarter 2019
- SHAREHOLDERS TO APPROVE TOD FINANCES' INVESTMENT IN CC&C - CC & C GETS CERTIFICATION BY ITS COMPETITIVENESS CLUSTER We held our General Assembly on May 9th.This was mainly an opportunity to ratify family office “TOD Finances” investment in the company....
read moreResults for the 4th quarter 2018
- PARTICIPATION IN CC & C - NEWS OF OUR RESEARCH PROJECTS TOD Finances, a french family office, is expected to invest 100,000 euros in our company by the end of February. This excellent news will allow us to hire a new researcher and launch new projects. In...
read moreResults for the 3rd quarter 2018
- RESULTS OF THE CALL FOR EUROPEAN PROJECTS FET-OPEN - A NEW RESEARCH PROJECT WITH THE UNIVERSITY OF MONTPELLIERWe have received the answer from the European Commission: unfortunately, it is negative. However, we get a very good grade, and the comments of the...
read more
Results for the second quarter 2018
- EUROPEAN GRANT APPLICATION FET OPEN: 1.8 MILLION EURO REQUESTED, RESPONSE ON OCTOBER 16TH, 2018 - AFTER STANFORD UNIVERSITY, NEW PARTNERSHIPS IN PERSPECTIVE On May 16th, we submitted an application for a grant of 1.8 million Euro from the European Commission as part...
read more
NanoStress: we answered the FET-Open call for projects
The FET-Open call of the European Commission finances disruptive innovation research projects capable of « changing the world ». We did not need it any less, so we submitted today a nomination file within the NanoStress consortium, in order to obtain the Proof of...
read more
Results for the first quarter 2018
- WITH THE SUPPORT OF INSERM, GET EUROPEAN FUNDS - LAST FUNDRAISE BEFORE CHANGING OUR FUNDING MODEL The FET-Open call for projects, which is part of the Horizon 2020 program for research initiated by the European Commission, selects its laureates for...
read more
About our trip to San Francisco
CC & C was honored to be one of the 3 high-tech start-ups selected in the 2017 NETVA program. As a reminder, NETVA, for New Technology Venture Accelarator, is a program sponsored by the French Embassy in Washington to develop scientific and industrial exchanges...
read more
Brief feedback on our trip to San Francisco, under the NETVA program – nov 2017
Rémy Brossel, CSO of Cell Constraint & Cancer went to present our technology in San Francisco and in the Bay Area, thanks to the support of the french Embassy. Contacts were made in particular with a (very) big university of the Bay for our project "Action of a...
read more
Our executive summary 2018
Our Executive Summary is updated. This version becomes our reference document for the year 2018. Do not hesitate to download it : Executive Summary anglais -...
read more
Our Exececutive Summary for 2017
Our revised Executive Summary was just released. It will become our reference document for the period 2017-2018. Please download it here:...
read more
Rémy Brossel will be in San Francisco in october, thanks to the Netva Programm
CC & C was selected to participate in October 2017 in a presentation of our activities in California under the NETVA program. The NETVA program (New Technology Venture Accelerator) offers young innovative startups in France a personalized support program, analysis...
read more
CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles
articles
Financial news
Results for the 2nd Quarter 2019
- FOLLOWING THE FAILURE OF OUR APPLICATION FOR A EUROPEAN SUBSIDY, ONE OF OUR SHAREHOLDER COMMITS TO RAISE THE BUDGET FOR PROOF OF EFFICACY - CC & C RECEIVES DELIVERANCE OF ITS PATENT FOR JAPAN AND THE USA On June 20th, we received the notification of rejection of...
read moreResults for the 1st Quarter 2019
- SHAREHOLDERS TO APPROVE TOD FINANCES' INVESTMENT IN CC&C - CC & C GETS CERTIFICATION BY ITS COMPETITIVENESS CLUSTER We held our General Assembly on May 9th.This was mainly an opportunity to ratify family office “TOD Finances” investment in the company....
read moreResults for the 4th quarter 2018
- PARTICIPATION IN CC & C - NEWS OF OUR RESEARCH PROJECTS TOD Finances, a french family office, is expected to invest 100,000 euros in our company by the end of February. This excellent news will allow us to hire a new researcher and launch new projects. In...
read moreResults for the 3rd quarter 2018
- RESULTS OF THE CALL FOR EUROPEAN PROJECTS FET-OPEN - A NEW RESEARCH PROJECT WITH THE UNIVERSITY OF MONTPELLIERWe have received the answer from the European Commission: unfortunately, it is negative. However, we get a very good grade, and the comments of the...
read more
Results for the second quarter 2018
- EUROPEAN GRANT APPLICATION FET OPEN: 1.8 MILLION EURO REQUESTED, RESPONSE ON OCTOBER 16TH, 2018 - AFTER STANFORD UNIVERSITY, NEW PARTNERSHIPS IN PERSPECTIVE On May 16th, we submitted an application for a grant of 1.8 million Euro from the European Commission as part...
read more
NanoStress: we answered the FET-Open call for projects
The FET-Open call of the European Commission finances disruptive innovation research projects capable of « changing the world ». We did not need it any less, so we submitted today a nomination file within the NanoStress consortium, in order to obtain the Proof of...
read more
Results for the first quarter 2018
- WITH THE SUPPORT OF INSERM, GET EUROPEAN FUNDS - LAST FUNDRAISE BEFORE CHANGING OUR FUNDING MODEL The FET-Open call for projects, which is part of the Horizon 2020 program for research initiated by the European Commission, selects its laureates for...
read more
About our trip to San Francisco
CC & C was honored to be one of the 3 high-tech start-ups selected in the 2017 NETVA program. As a reminder, NETVA, for New Technology Venture Accelarator, is a program sponsored by the French Embassy in Washington to develop scientific and industrial exchanges...
read more
Brief feedback on our trip to San Francisco, under the NETVA program – nov 2017
Rémy Brossel, CSO of Cell Constraint & Cancer went to present our technology in San Francisco and in the Bay Area, thanks to the support of the french Embassy. Contacts were made in particular with a (very) big university of the Bay for our project "Action of a...
read more
Our executive summary 2018
Our Executive Summary is updated. This version becomes our reference document for the year 2018. Do not hesitate to download it : Executive Summary anglais -...
read more
Our Exececutive Summary for 2017
Our revised Executive Summary was just released. It will become our reference document for the period 2017-2018. Please download it here:...
read more
Rémy Brossel will be in San Francisco in october, thanks to the Netva Programm
CC & C was selected to participate in October 2017 in a presentation of our activities in California under the NETVA program. The NETVA program (New Technology Venture Accelerator) offers young innovative startups in France a personalized support program, analysis...
read more
CELL CONTRAINT & CANCER
le Mas l’Hermite
331 chemin de la Poterie
f13280 Raphèle les Arles